跳至主要内容
临床试验/NCT02464267
NCT02464267已完成不适用

Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation of Patients Living With Cystic Fibrosis - Item Development

University of Zurich1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
1
主要终点
Change in patient experience of symptom management

研究概览

简要总结

The aim of this study is to develop a reliable and valid instrument to measure symptom management (experience and / or management strategies) during exacerbation episodes in CF patients. For the development a sequential exploratory two phase mixed-method study will be applied. In a first step, up to 25 CF patients will be interviewed: approximately 15 CF patients who experienced at least one episode of exacerbation in the past year and approximately CF 10 patients who are currently experiencing an exacerbation. The latter group will be interviewed up to 3 times during and after the antibiotic treatment. The instruments initial item list will be developed on basis of the interviews. Up to five health professionals will rate the items' relevance. In a further step, items' clarity and relevance will be assessed by cognitive debriefing interviews with no more than 10 patients. In the last step (part III), the instrument's preliminary construct and concurrent validity and reliability will be tested in a larger sample up to 150 patients experiencing exacerbation. Patients will be asked to complete the newly developed questionnaires and a set of other questionnaires at one time point. For part III, ethic approval will be asked at a later date (2015).

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Part I A & II:
  • Patients with a confirmed diagnosis of cystic fibrosis
  • Experience of at least one exacerbation during the last year requiring antibiotic treatment (oral or intravenous)
  • Patients with a confirmed diagnosis of cystic fibrosis
  • Experience of an acute exacerbation requiring antibiotic treatment (oral or intravenous)

排除标准

  • Part I & II
  • Do not speak or understand German
  • Inability to verbally communicate
  • Cognitive impairment

结局指标

主要结局

Change in patient experience of symptom management

时间窗: Patients will be followed up for 4 weeks after start of antibiotic treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验